The new funding round will help advance their iPSC-derived dopaminergic neuronal precursor cell trials, manufacturing, and continued development of other iPSC therapies.
The new grant will help expand REPROCELL’s stem cell manufacturing capabilities and support Maryland’s growing regenerative medicine sector.
Keensight Capital’s investment aims to accelerate Isto Biologics’ growth and international expansion in the orthobiologics sector.
Eight California research centers receive funding to expand cell and gene therapy manufacturing.
The latest funding round backs 11 Maryland-based projects focused on advancing therapies and growing regenerative medicine manufacturing.
The new grants will support diverse early-stage research projects, aiming to advance regenerative medicine tools and future therapies.
The technology aims to generate safer heart muscle cells for cardiovascular disease therapies and research.
This latest funding round will hopefully empower more research, trials, and commercialization.
